546.SI
BuySecond WindFLAGMedtecs International Corporation Limited · Healthcare · Taiwan · $55M · Avg Vol: $168K/d
Second Wind: Cheap and rising again, but the business does not yet earn the optimism.
Insufficient evidence for a screen-pass. Medtecs International Corporation Limited: fails the quant gate on quality (Q47/V57/M61; every leg must be >= 50). Absence of evidence is neutral; nothing adverse is known.
The ranks quoted here are from the day it was written; today's Quality, Value and Momentum are the bars above.
ABOUT MEDTECS INTERNATIONAL CORPORATION LIMITED
Read
Medtecs International Corporation Limited is a leading manufacturer and distributor of medical consumables, personal protective equipment (PPE), and provider of hospital laundry services. The company operates a vertically integrated supply chain with manufacturing facilities in the Philippines, Cambodia, and Taiwan, serving a global healthcare client base. Its long-term institutional contracts for hospital linen management in Taiwan and the Philippines provide highly stable, recurring revenue.
FINANCIAL SUMMARY (SGD)
| Year | 2021 | 2022 | 2023 | 2024 | 2025 | CAGR | TTM |
|---|---|---|---|---|---|---|---|
| Revenue | — | 71.7M | 67.2M | 69.4M | 100.7M | 12.0% | 108.2M |
| EPS (SGD) | 0.04 | -0.07 | -0.05 | -52.50 | -0.01 | — | -0.01 |
| Shares | — | 544.9M | 544.9M | 544.9M | 544.9M | 0.0% | 544.9M |
| Debt | — | 24.9M | 34.3M | 28.4M | 27.7M | 3.5% | 27.2M |
| Equity | — | 191.1M | 164.8M | 136.0M | 129.6M | -12.1% | — |
| Op CF | — | 1.6M | -9.2M | 0.4M | -3.1M | -50.3% | 2.5M |
| Inv CF | — | -37.2M | 12.3M | -3.5M | 2.1M | — | — |
| Fin CF | — | -3.8M | 2.3M | -6.9M | -0.7M | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 546.SI are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| 546.SI | Medtecs International Corporation Limited(you) | $55M | 74 | Buy |
| 6527.TWO | Crystalvue Medical Corporation | $60M | 85 | Strong Buy |
| 4116.TWO | BenQ Medical Technology Corporation | $56M | 96 | Strong Buy |
| 1752.TW | Nang Kuang Pharmaceutical Co., Ltd. | $102M | 88 | Strong Buy |
| 1565.TWO | St.Shine Optical Co.,Ltd. | $156M | 67 | Buy |
| 1783.TW | Maxigen Biotech Inc. | $115M | 89 | Strong Buy |
| 1786.TW | SciVision Biotech Inc. | $112M | 48 | Hold |
| 4126.TWO | Pacific Hospital Supply Co., Ltd | $178M | 96 | Strong Buy |
| 4107.TWO | Bioteque Corporation | $250M | 98 | Strong Buy |
| 6612.TWO | ICARES Medicus, Inc. | $116M | 34 | Sell |
Peer medians: ROE 4.9% · P/E 15.5x · Gross margin 42.4%
Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.